Here’s whether Pfizer Inc. (PFE) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+1.14% over 10 days); 3-month momentum positive (+8.4%). Concerns: RSI 78 — overbought, elevated pullback risk. Currently 2.4% off its 52-week high. Score: +4/7.
PFE is in a confirmed uptrend, trading above both its 50-day ($25.36) and 200-day ($25.99) moving averages. With an RSI of 77.9, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +9.1% compares to +20.5% for SPY (trailed the market by 11.4%).
$10,000 invested 1 year ago→ $10,905 today
vs. S&P 500 (SPY) — same period trailed market by 11.4%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($25.99)
✓Above 50-day MA ($25.36)
!RSI(14) neutral zone (30–70) — currently 77.9
✓Positive return (+9.1%)
✓Within 10% of period high (−2.4%)
Period Range $28.07
$23.58$28.75
RSI (14) 77.9
0 · OversoldOverbought · 100
Key Metrics
Price$28.07
Period Return+9.1%
Period High$28.75
Period Low$23.58
Drawdown−2.4%
MA-50$25.36
MA-200$25.99
RSI (14)77.9
Avg Volume (30d)40.2M
vs. SPYtrailed by 11.4%
Return Rank#491 of 999
Trend Signals
Price is above the 200-day moving average ($25.99)